Target intelligence / Profile preview

Spalt-like transcription factor 1 (SALL1)

Target
SALL1
Molecular classification
Transcription factor, Zinc finger protein, DNA-binding protein, Chromatin regulator (NuRD complex association)
01

Overview

Spalt-like transcription factor 1 is a member of the SALL family of zinc finger transcription factors, distinct for its DNA-binding specificity toward A/T-rich sequences via C-terminal and double zinc finger domains. It localizes to heterochromatin, orchestrates gene repression, and is required for normal development, particularly of the kidney and other organs. Mutations in SALL1 cause Townes-Brocks syndrome, manifesting as multisystem developmental defects. SALL1 is implicated in chromatin remodeling, likely through interactions with the NuRD histone deacetylase complex, and regulates STEM cell and microglia identity by fine-tuning chromatin accessibility and transcriptional programs.

Other names
Sal-like protein 1SAL1ZNF794HSal1Sal-1HSAL1TBSZinc finger protein 794Zinc finger protein SALL1Zinc finger protein Spalt-1HEL-S-89epididymis secretory protein Li 89
02

Mechanism of action

No approved drugs or tool compounds directly targeting SALL1. Mechanistic studies focus on loss- or gain-of-function interventions in model systems for disease modeling or cellular identity.

03

Biological functions

Organogenesis (especially kidney, limb, ear, heart)Transcriptional repressionDNA-binding (specifically to A/T-rich DNA sequences)Cell differentiationChromatin remodeling (NuRD complex interaction)
04

Disease associations

Townes-Brocks syndrome (TBS)Bronchio-oto-renal syndromeKidney malformationsDevelopmental anomalies (limb, ear, anal, heart)
05

Safety considerations

Therapeutic targeting of SALL1 could risk loss of essential developmental functions, organogenesis failure, and broad transcriptional dysregulation, given its role as a master regulator in multiple tissues
06

Biomarkers

SALL1 mutations (especially coding sequence deletions or dominant-negative variants) serve as genetic biomarkers for Townes-Brocks syndrome and associated congenital malformations

Beyond the preview

Go deeper on Spalt-like transcription factor 1 (SALL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spalt-like transcription factor 1 (SALL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call